Research Article | Volume: 7, Issue: 7, July, 2017
Research Article | Volume: 7, Issue: 7, July, 2017
Antimalarial medications remain one of the major interventional tools for the global malaria control efforts. One of the most popular Ghanaian herbal antimalarial agent is the product sold under the trade name ‘Adutwumwaa malamix’. This product is registered with the Food and Drugs Authority (FDA) of Ghana as treatment of uncomplicated malaria. In this study, the safety and effectiveness of the product ‘Adutwumwaa malamix’ for the treatment of uncomplicated malaria was clinically evaluated based on disease-oriented and patient-oriented evidence. A total of 42 subjects were recruited for the study. Complete cure was achieved for 35 (83.33%) of participants by day 7 of the study. Partial efficacy was also achieved for 7 (16.66%) of subjects. Patient reported symptoms such fever, chills and abdominal pains were also significantly improved by day 7 and absent by day 28. The safety parameters assessed did not show any clinically significant change among the study population during treatment. The outcome of the study indicates that the Ghanaian herbal antimalarial agent ‘Adutwumwaa malamix’ may be an effective herbal treatment for the management of uncomplicated malaria.
Tetteh AW, Mensah MLK, Boadu KO, Thomford KP, Agyeman MO, Annan K, Dickson RA, Mensah AY, Amponsah IK, Ekuadzi E, Owusu-Ansah ED. Clinical Evaluation of the Safety and Effectiveness of Adutwumwaa Malamix: A Polyherbal Product for the Treatment of Uncomplicated Malaria In Ghana. J App Pharm Sci, 2017; 7 (07): 040-045.
Year
Month